{
    "data": {
        "attributes": {
            "action": "require pharmaceutical companies that sell drugs in the UK to devote a certain amount of R&D expenditure to diseases of the poor",
            "action_prefix": "We the undersigned petition the Prime Minister to",
            "background": "Following on from recent news (February 2009) that GlaxoSmithKline, amongst others, will reduce the prices of drugs to third world countries, and share their patent pool; we, the undersigned, would request that HM Government investigate ways in that any pharmacuetical company selling pharmaceutical drugs in the UK are obliged to devote a certain amount of their R&D expenditure towards tackling the diseases that affect Third World countries, rather than leaving this important task to charitable organisations such as the Bill and Melissa Foundation.",
            "closed_at": "2010-03-16T00:00:00Z",
            "created_at": "2009-03-13T22:01:58.056007Z",
            "creator_name": "Patrick Mullin",
            "government_response_at": null,
            "government_responses": null,
            "opened_at": "2009-03-13T22:01:58.056007Z",
            "rejected_at": null,
            "rejection": null,
            "signature_count": 7,
            "state": "finished",
            "updated_at": "2010-03-17T03:01:36.975976Z"
        },
        "id": 11997072
    },
    "links": {
        "original": "http://petitions.number10.gov.uk/ThirdWorldDrugs/"
    },
    "type": "petition"
}